Roflumilast topical 0.3% foam
20251829
Phase 2 small_molecule active
Quick answer
Roflumilast topical 0.3% foam for Non-segmental Vitiligo is a Phase 2 program (small_molecule) at Arcutis Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcutis Biotherapeutics
- Indication
- Non-segmental Vitiligo
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active